Melanoma, Ocular
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I) (NCT05169957) | University of Michigan Rogel Cancer Center | 2022-08-09 |
| Clinical Outcomes and Biomarkers in Patients With Stage 0-IV Melanoma in Real Clinical Practice (NCT05402059) | MelanomaPRO, Russia | 2022-03-02 |
| Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma (NCT02678572) | Delcath Systems Inc. | 2016-02-01 |
Track Melanoma, Ocular automatically
Every clearance here is in the API, with alerts when new ones post.